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Clinical relevance of reduced 
decorrelation signals in the diabetic 
inner choroid on optical coherence 
tomography angiography
Yoko Dodo, Kiyoshi Suzuma, Kenji Ishihara, Shin Yoshitake, Masahiro Fujimoto, Tatsuya 
Yoshitake, Yuko Miwa & Tomoaki Murakami
Diabetes induces lesions of the retinal and choroidal capillaries, which promote the pathogenesis of 
diabetic retinopathy (DR). The decorrelation signals in optical coherence tomography angiography 
(OCTA) represent the blood flow and vascular structure, and three-dimensional OCTA images enable 
individual capillary layers to be evaluated separately. The current study documented that en-face 
OCTA images revealed spots of flow void in the choriocapillaris layer in eyes with DR. Quantitative 
investigation demonstrated that non-flow areas within the central subfield (CSF) increased in eyes 
with more severe DR grades. The non-flow areas in the choriocapillaris layer were also associated 
with poorer visual acuity (VA) in all 108 eyes. A modest correlation was noted between the areas of 
flow void and poorer VA in 69 eyes without DME, whereas the non-flow areas were not related to VA 
or to CSF thickness measured by OCT in 39 eyes with DME. In 12 eyes with ischemic maculopathy, the 
choriocapillaris layer beneath the disrupted ellipsoid zone of the photoreceptor (EZ) had greater areas 
of flow void than did the area beneath an intact EZ. These data suggested that disrupted choroidal 
circulation has clinical relevance and contributes to the pathogenesis of DR.
Diabetic retinopathy (DR), which is a diabetic microangiopathy, often leads to severe visual impairment1. 
Therapeutic strategies, including anti-vascular endothelial growth factor (VEGF) therapy, photocoagulation, and 
vitrectomy, have been widely used to treat vision-threatening DR, e.g., proliferative diabetic retinopathy (PDR) and 
diabetic macular edema (DME). However, patients with diabetes often have poor visual prognosis2–4. Further inves-
tigations should elucidate the pathogenesis in the chorioretinal vessels and its effect on neuroglial dysfunction5, 6.
In the physiologic state, the inner and outer retinal layers are nourished via the retinal and choroidal vessels, 
respectively, and diabetes impairs the function and structure of these vessels. The choroidal vessels are composed 
of hierarchical structures that are represented by their layers. From the short posterior ciliary arteries, larger 
and smaller vessels in Haller’s layer and Sattler’s layer bifurcate into fine meshwork-like capillaries with small 
intercapillary spaces in the choriocapillaris layer7–9. The choroidal system nourishes the outer retinal layers in 
concert with the retinal pigment epithelium (RPE) and Bruch’s membrane10. A few histologic publications have 
documented the morphologic changes in the choroidal vasculature and periodic acid-Schiff positive deposits in 
the stroma and have proposed “diabetic choroidopathy” as another diabetic microangiopathy11, 12. In addition to 
the arteriosclerotic changes or vascular luminal narrowing in the larger choroidal vessels, capillary dropout in 
the choriocapillaris layer suggests ischemic changes in the outer retinal layers13. However, the in vivo relationship 
between the choriocapillaris and the outer retinal layers has not been investigated in diabetic eyes14.
Recent advances in fundus imaging have promoted the understanding of the pathogenesis in DR. 
Enhanced-depth imaging of spectral-domain optical coherence tomography (OCT) and swept-source OCT 
have particularly enabled both the qualitative and the quantitative in vivo evaluation of choroidal structure15, 16. 
Whether the quantified choroidal thickness is associated with DR severity or DME remains controvesial17–24. 
Recent publications have documented several morphologic changes in the choroidal vasculature in Sattler’s layer 
or Haller’s layer in diabetic eyes25, 26. OCT angiography (OCTA), in which the decorrelation signals derive mainly 
from the movements of erythrocytes, delineates the three-dimensional vascular structure27–30. In healthy eyes, the 
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decorrelation signals are depicted in the inner choroidal layers, whereas the signals decrease or disappear in the 
lesions of several chorioretinal diseases31, 32. However, it is largely unknown how OCTA delineates the flow void 
in the choriocapillaris layer in eyes with DR.
In the current study, we evaluated the decorrelation signals in the choriocapillaris layer on OCTA images and 
their association with DR severity and pathogenesis in retinal lesions in DR.
Results
Characteristics of decorrelation signals in the choroidal capillary slab in diabetic eyes. After 
excluding 93 eyes that met the exclusion criteria, 108 eyes of 66 consecutive patients with diabetes mellitus were 
evaluated. The patients’ characteristics are presented in Table 1. Qualitative investigation indicated that the OCTA 
images revealed that the mosaic of the higher decorrelation signal was accompanied by tiny dots with lower 
signal intensity in the en-face choroidal capillary images in eyes with no apparent retinopathy (Figs 1 and 2). By 
contrast, spots of flow void were often observed in eyes with nonproliferative DR (NPDR) or PDR (Fig. 3). Eyes 
with moderate NPDR or with more severe grades often exhibited larger lesions of flow void. These features were 
accompanied by a vessel-like flow signal, which might correspond to either choroidal vessels or projection arti-
facts from retinal vessels (Figs 4 and 5).
Further quantification demonstrated that the areas of flow void did not differ among the central subfield (CSF) 
and the superior, nasal, temporal, and inferior subfields in the parafovea of the modified Early Treatment Diabetic 
Retinopathy Study (ETDRS) grid (3.25 ± 1.85%, 2.93 ± 1.69%, 2.91 ± 1.53%, 3.00 ± 1.76%, and 3.04 ± 1.55%, 
respectively; p = 1.000 for all comparisons) after the projection artifacts and shadow artifacts were carefully 
removed (Fig. 1).
Clinical relevance of flow void in the choroidal capillary slab. We evaluated how the areas of flow 
void in the CSF were associated with systemic and ocular parameters. We prepared the en-face OCTA images of 
choroidal capillary slab (~29 μm thickness) according to the default setting (Fig. 6A). Eyes with severe NPDR 
or PDR had greater areas of flow void than those with no apparent retinopathy (Fig. 6A). On the ~10-μm-thick 
choriocapillaris slab images, the areas increased gradually according to the DR severity, and eyes with moderate 
NPDR, severe NPDR, and PDR had significantly larger areas of flow void than those with no apparent retinopathy 
(p = 0.032, p = 0.009, and p = 0.002, respectively) (Fig. 6B). We selected the non-flow areas in the 10-μm-thick 
slab images for further evaluation to investigate the clinical relevance of the flow void in the choriocapillaris layer. 
In 69 eyes without center-involved DME, the areas of flow void tended to increase as the DR severity progressed, 
and eyes with severe NPDR or PDR had larger non-flow areas than those with no apparent retinopathy (Fig. 6C). 
By contrast, we found no associations of the non-flow areas with systemic factors, i.e., age, hemoglobin A1c, dia-
betes duration, systemic hypertension, or dyslipidemia (data not shown).
Further statistical analyses showed that the logarithm of the minimum angle of resolution visual acuity (log-
MAR VA) was modestly associated with the non-flow areas within the CSF in either all 108 eyes or 69 eyes with-
out center-involved DME (Fig. 7A,B). By contrast, no relationship was observed between the areas of flow void 
and logMAR VA in eyes with center-involved DME (Fig. 7C). No differences in the non-flow areas were noted 
between eyes with and without center-involved DME (p = 0.150), and the CSF thickness was not correlated with 
the non-flow areas in eyes with center-involved DME (Fig. 7D).
We compared the areas of flow void in the regions with and without intact ellipsoid zone of the photoreceptor 
(EZ) lines in 12 eyes with ischemic maculopathy among 108 eyes. Within the non-flow areas in the deep retinal 
capillaries, the regions without intact EZ lines had greater non-flow areas in the choriocapillaris layer than those 
with intact EZ lines (6.28 ± 3.34% vs. 2.00 ± 1.10%; p < 0.001) (Fig. 5).
Discussion
This retrospective study showed larger areas of flow void in the inner choroid in eyes with moderate NPDR, 
severe NPDR, and PDR than those with no apparent retinopathy. Since the choroid nourishes the outer retinal 





NPDR Severe NPDR PDR
Eyes/patients 11/6 8/5 47/31 15/11 27/17
Age (years) 64.8 ± 11.7 71.5 ± 19.6 67.1 ± 10.9 60.7 ± 9.8 52.9 ± 12.4
Men/women 5/1 3/2 24/7 9/2 12/5
Diabetes duration (years) 13.7 ± 2.3 13.0 ± 2.9 9.8 ± 6.9 14.2 ± 7.4 9.8 ± 8.1
HbA1c (%) 7.33 ± 1.91 6.75 ± 0.35 7.61 ± 1.77 7.54 ± 0.78 7.57 ± 1.38
Systemic hypertension (present/absent) 2/4 5/0 18/13 7/4 11/6
Dyslipidemia (present/absent) 1/5 2/3 10/21 3/8 4/13
LogMAR VA −0.033 ± 0.175 0.095 ± 0.212 0.038 ± 0.159 0.068 ± 0.184 0.104 ± 0.258
Center-involved DME — 4 eyes 14 eyes 10 eyes 11 eyes
Ischemic maculopathy — 0 eye 0 eye 6 eyes 6 eyes
CSF thickness (µm) 244 ± 36 290 ± 58 284 ± 61 346 ± 69 325 ± 120
SSI 70.8 ± 4.9 68.5 ± 5.8 67.3 ± 5.4 66.2 ± 4.7 70.0 ± 6.6
Table 1. Patient characteristics.
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contribute to retinal ischemia and concomitant expression of VEGF10, 33. Intriguingly, the non-flow areas in the 
choriocapillaris layer were associated with poorer VA and disrupted photoreceptor cells, thus indicating their 
clinical relevance and suggesting the pathological contribution of disrupted choroidal circulation to neuroglial 
impairment in DR.
Histological publications showed that the intercapillary spaces in the choriocapillaris layer in the macula were 
much smaller than those in the retina7, 34. Since the lateral resolution on en-face OCTA images was not high, we 
could not definitively recognize the choroidal capillaries but could recognize the retinal capillaries on 3 × 3-mm 
en-face OCTA images8. This encouraged us to investigate the areas of flow void as an index of diabetes-induced 
dropout of capillaries in the choriocapillaris layer rather than the vascular structure per se11, 13. A choriocapillaris 
lobule in the macula with a diameter that ranges from dozens to hundreds of micrometers is fed by an arteriole, 
Figure 1. Tiny dots of flow void in the choriocapillary layer in a 60-year-old patient with no apparent 
retinopathy. The en-face OCTA images in the superficial retinal layer (A) and the choriocapillaris layer (10 
μm thick) (C) and structural OCT image at the RPE level (B). The corresponding B-scan images along the 
green arrow in panel A with (D,F) or without (E) the decorrelation signals (red). Red or green lines revealed 
the segmentation of individual layers. (G,H) The binary images of panels A and B using the global threshold 
in ImageJ. (I) The binary image of panel C using the mean decorrelation signal in the outer retina as the cutoff 
value. (J) The merged image of panel H with the inverted signal and panel G means the projection artifacts and/or 
shadow artifacts. (K) The areas of flow void in the choriocapillaris layer (black) after removing the artifacts. (I) The 
merged image of panels C (grayscale), (J) (green), and (K) with inverted signals (red). Scale bar = 500 μm.
www.nature.com/scientificreports/
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and the dark spots of a similar size on OCTA images might represent disrupted blood flow in this unit9. The 
non-flow areas with extended and undefined shapes might correspond to the histologic capillary dropout in the 
choriocapillaris layer.
OCTA showed that among several diseases with flow void in the inner choroid, geographic atrophy (GA) had 
significantly attenuated decorrelation signals in the choriocapillaris layer32. Eyes with DR and GA appeared to 
share these characteristics in vascular morphology. By contrast, the boundary was indefinite, and the decorre-
lation signals were mildly attenuated in the most choroidal lesions in DR compared with GA35, 36. Theoretically, 
OCTA does not allow us to know the definite absence of in vivo blood flow, and the decorrelation signals rep-
resent the limited range of flow velocity36. Further advances in fundus imaging technology should elucidate the 
structural and functional changes in choroidal vessels more definitively.
The areas of flow void were extended in the choriocapillaris layers as DR progressed. Systemic factors, includ-
ing hyperglycemia and hypertension, might be common upstream regulators of both retinal and choroidal vascu-
lar lesions37, 38. Another possibility might be that VEGF from the retinas in DR increases Intercellular Adhesion 
Molecule (ICAM) expression, and concomitant leukostasis exacerbates capillary nonperfusion in the chorio-
capillaris layer39, 40. Alternatively, the circulatory disturbance in the choroid might contribute to DR progression. 
The outer retinal layers are nourished by the choroidal circulation in healthy eyes. Disrupted blood flow in the 
choroid would contribute to outer retinal ischemia, which would promote VEGF expression and subsequent 
DR progression33. VEGF expression is increased mainly in ganglion cells, astrocytes, Müller cells, and RPE in 
diabetic retinas, and a future study should evaluate whether VEGF is up-regulated in the photoreceptors in eyes 
with disrupted choroidal circulation41. Another explanation might be that diabetes-induced damage to the RPE, 
which contributes to the maintenance of capillaries in the choriocapillaris layer, might promote capillary dropout 
in the inner choroid42–44.
A recent publication reported the association between deep retinal capillary nonperfusion and photoreceptor 
disruption in diabetic macular ischemia45. We found that disrupted choroidal circulation is associated with pho-
toreceptor damage and visual impairment within the areas of the deep retinal capillary nonperfusion. A defi-
ciency in oxygen or nutrients from the chorioretinal capillaries could contribute to photoreceptor damage. Three 
of 12 eyes had center-involved DME, which could also induce photoreceptor damage and be a confounding factor 
for the analyses in this study. Further study of a large cohort should be planned to elucidate the processes involved 
in the damage to photoreceptors and choroidal circulation.
Classical fundus imaging using fluorescent dyes delineated hypofluorescence in the choroidal flush phase of 
fluorescein angiography or the early phase of indocyanine green angiography in DR, suggesting disruption in 
choroidal blood flow46, 47. These modalities provide two-dimensional data, whereas three-dimensional OCTA 
images specifically depict the motion contrast images in the inner choroidal layer. Another modality, laser 
Doppler flowgraphy, allows the measurement of flow velocity, although OCTA images show a limited range of 
velocity33, 36. Comparative studies would improve the understanding of disrupted choroidal circulation in DR.
The current study had several limitations, e.g., its retrospective nature and the small number of cases. We 
carefully excluded the areas with projection artifacts from the retinal vessels and shadow cast by retinal lesions 
with higher OCT reflectivity; however, it is unclear how these artifacts might influence the non-flow areas in the 
inner choroidal layers48. We had to recognize the limited generalizability because we used one of the major OCTA 
devices to image structures in Asian patients who contain higher amounts of pigment in the RPE and choroid. 
Another population-based study should be planned to compare the flow void between nondiabetic and diabetic 
Figure 2. The mosaic with higher or lower intensity decorrelation signals in the choriocapillaris layer of a 
healthy eye. The 10-μm-thick en-face OCTA (A) and OCT (B) images in the choriocapillaris layer. (C) A binary 
image reveals the areas of flow void (black) after the removal of the artifacts. B-scan image with (D) and without 
(E) decorrelation signals along the green arrow in (B). (F) The intensity of the decorrelation signal along the 
green line in B. Scale bar = 500 μm.
www.nature.com/scientificreports/
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subjects and to evaluate the reproducibility in other races, including other participants in whom systemic param-
eters are normalized, and using other devices.
In conclusion, we documented the lesions with attenuated decorrelation signals in the inner choroid in DR 
and their association with visual impairment and photoreceptor damage, suggesting the clinical relevance and 
pathophysiology of choroidal circulation in eyes with DR.
Methods
Patients. We retrospectively reviewed 108 consecutive eyes of 66 patients with DR who visited the 
Department of Ophthalmology of Kyoto University Hospital from February 2015 to August 2016. Eyes with DR 
were included when OCTA images of sufficient quality were acquired using Optovue RTVue XR Avanti (Optovue, 
Fremont, CA). The exclusion criteria were the presence of other chorioretinal diseases, glaucoma or ocular hyper-
tension; an axial length shorter than 22.0 mm or longer than 26.0 mm; intraretinal or preretinal hemorrhages or 
hard exudates with diameters larger than one-third of the disc diameter within the central 3 × 3-mm square on 
the color fundus photograph; a history of any intervention for macular lesions; intraocular surgery other than 
cataract extraction; and cataract surgery within 6 months of study enrollment. We excluded eyes with a history of 
photocoagulation of the macular area because the decorrelation signals in the choriocapillaris layer were atten-
uated after this treatment49. To guarantee image quality, we also excluded eyes with a signal strength index (SSI) 
score of 60 or less50. Thirty-nine eyes had center-involved DME, which was determined by two-dimensional 
mapping constructed using the same dataset. According to the previously reported equation, the cutoff value for 
the CSF thickness was 299.52 µm on Optovue images, which corresponds to 250 µm on OCT images obtained by 
Stratus OCT (Carl Zeiss Meditec AG, Oberkochen, Germany)51, 52. We thus determined that the eyes with a CSF 
thickness exceeding 299.52 µm had center-involved DME in the current study.
All research and measurements adhered to the tenets of the Declaration of Helsinki. The Kyoto University 
Graduate School and Faculty of Medicine Ethics Committee approved the study protocol. All participants pro-
vided written informed consent before inclusion in the study.
Figure 3. Spots of flow void in the choriocapillaris layer of a 53-year-old patient with severe NPDR. The en-
face OCTA images in the superficial retinal layer (A) and the 10-μm-thick choriocapillaris layer (C) and the 
structural OCT images in the RPE (B) and the choriocapillaris layer (D). (E) The merged image of panels C 
(red) and D (grayscale). (F) The en-face binary image of projection and/or shadow artifacts created from panels 
A and B. (G) The binary images of the non-flow areas (black) in the choriocapillaris layer after artifact removal. 
(H) The merged image of panel C (grayscale), (F) (green), and (G) with inverted signals (red). (I,J) B-scan 
images with and without decorrelation signals (red) along the green arrow in panel E. (K) The intensity of the 
decorrelation signals along the green arrow in panel E. The arrowheads in panels C,I, and K indicate spots of 
flow void. Scale bar = 500 μm.
www.nature.com/scientificreports/
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OCTA. We performed a comprehensive ophthalmic examination including the color fundus photography 
(TRC-NW8F; Topcon Corp, Tokyo, Japan) and the measurement of the axial length using partial coherence inter-
ferometry (IOLMaster, Carl Zeiss Meditec AG). The best-corrected decimal VA was converted to logMAR VA. 
OCTA images in the 3 × 3-mm square centered on the fovea were obtained using the Optovue RTVue XR Avanti 
(Fig. 1). Given the high A-scan speed of 70,000 scans/second and a light source of approximately 840 nm, this 
instrument delineates motion-dependent decorrelation signals using the split-spectrum amplitude decorrelation 
angiography algorithm. Briefly, three-dimensional scans are comprised of two consecutive B-scans (M-B frames) 
at a fixed position. The calculation of the decorrelation between the sequential images enables the detection of the 
motion of the blood cells and concomitant construction of a motion contrast AngioFlow image.
We applied segmentation processes to create the en-face OCTA images in the choroidal capillary slab, the 
retinal superficial and deep capillary plexus layers, and the avascular outer retina and the en-face structural OCT 
images in the RPE slab using the manufacturer’s software. The choroidal capillary slab images using the default 
Figure 4. Larger lesions with reduced decorrelation signals in the choriocapillaris slab in a 68-year-old patient 
with PDR. (A,B) The 10-μm-thick en-face OCTA and structural OCT images in the choriocapillaris layer. The 
en-face OCTA image in the superficial retinal layer (C) and the structural OCT image at the RPE level (D). (E) 
The binary image of panel A using the mean decorrelation signal in the outer retina as the cutoff value. (F) The 
binary image of the projection artifacts and/or shadow artifacts created from panels C and D. (G) The binary 
image of the areas of flow void after the removal of the areas with the artifacts. (H) The merged image of panel 
A (grayscale), (G) with inverted signals (red), and the binary image of artifacts (F; green). (I,J) B-scan images 
with and without decorrelation signals (red) along the green arrow in (B). (K) The intensity of the decorrelation 
signals along the green arrow in (B). (L) The en-face OCTA image in the deep retinal capillary layer. (M) The 
merged image of panels A (grayscale) and L (red). (N,O) The sectional image along the green arrow in panel M 
and its magnified image demonstrate that the EZ line is not intact in the areas of flow voids in both the retinal 
and the choroidal capillaries (between the arrowheads). (O) The white or black arrows in (I,K, and O) indicate 
the areas of flow void in the choriocapillaris layer. Scale bar = 500 μm.
www.nature.com/scientificreports/
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setting in the manufacturer’s software corresponded to the inner choroidal slab images extending from 31 to 
59 μm posterior to the RPE-Bruch membrane complex segmentation. According to a publication documenting 
in vivo thicknesses in the choriocapillaris-Sattler’s layer complex and Haller’s layer, the choroidal capillary slab 
might correspond to parts of the choriocapillaris-Sattler’s layer complex in most eyes53. Additionally, we prepared 
the ~10-μm-thick en-face images in the choriocapillaris layer (from 31 to 40 μm posterior to the RPE-Bruch 
Figure 5. Association between photoreceptor damage and flow void in the choriocapillaris layer in a 
46-year-old patient with PDR. En-face OCTA images in the 10-μm-thick choriocapillaris layer (A) and the 
superficial (B) and deep (C) retinal capillary layers. (D) The merged image of the superficial and deep layers 
reveals ischemic maculopathy. The binary images of the flow void (E) or the artifacts (F). (G,H) The merged 
images of the deep capillary layer (panel C) and panel E or F with inverted signals (green). Both EZ status 
and decorrelation signals in the choriocapillaris layer were evaluated along the 10 gray lines. (I,J) The B-scan 
images with and without decorrelation signals (red) along the blue arrow in panels G and H demonstrate that 
the EZ line is not intact in the central region (arrowheads). The magnified images of areas of flow void (green; 
K,M) and those without the artifacts (green; L,N) within the blue rectangle in panels G and H. (K,L) The red lines 
correspond to the ‘not intact’ EZ line in panel I and partly colocalize with the areas of flow void. (M,N) The blue lines 
correspond to the ‘intact’ EZ line in panel I and rarely colocalized with the non-flow areas. Scale bar = 500 μm.
www.nature.com/scientificreports/
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membrane complex) according to a recent publication54. The corresponding structural OCT images were also 
created to assess shadow artifacts. The retinal superficial or deep slab OCTA images showed the superficial layer 
from the inner boundary 3 μm beneath the internal limiting membrane (ILM) to the outer boundary 15 μm 
beneath the inner plexiform layer (IPL) or the deep layer from the inner boundary 15 μm beneath the IPL to the 
outer boundary 70 μm beneath the IPL. The en-face images in the avascular outer retina were from the inner 
boundary 70 μm below the IPL to the outer boundary located 30 μm below the RPE reference. Given that most 
shadow artifacts from the intraretinal lesions are clearly depicted in the RPE, we created an en-face structural 
OCT slab (~28 μm thick) at the level of the RPE as described recently50. These images were exported into ImageJ 
(NIH, Bethesda, MD) for image processing and analyses.
We then quantified the areas of flow void in the choroidal capillary slab in individual subfield of the modified 
ETDRS grid, including the central subfield (1 mm diameter) and the parafoveal quadrants (superior, inferior, 
nasal, and temporal subfields from 1 mm to 2.5 mm diameter), after the removal of the areas with projection arti-
facts and shadow artifacts as described recently50. Histologic publications suggested that this instrument cannot 
detect the specific morphology of the normal vascular network in the choriocapillaris layer within the macular 
area7–9. We thus evaluated the intensity of the decorrelation signals as the index of blood flow but not the vascular 
structure per se in the choriocapillaris layer. The preliminary study showed that the decorrelation signals are 
occasionally increased in the dilated capillaries around the nonperfused areas, which might incorrectly increase 
the average signal intensity. We therefore determined the mean decorrelation signals in the avascular outer retina 
as the cutoff value and measured the areas with decorrelation signals below the threshold to assess the disrupted 
blood flow.
We first calculated the mean levels of decorrelation signals in the avascular outer retina of every eye individ-
ually and used them as the individual threshold of the flow void in two en-face OCTA images of the choroidal 
capillary layer, i.e., the inner choroidal slab image using the default setting of the manufacturer’s software (from 
31 to 59 μm posterior to the RPE-Bruch membrane complex segmentation) and the 10-μm-thick choriocapillaris 
slab image (from 31 to 40 μm posterior to the RPE-Bruch membrane complex) (Fig. 1I)50. We further created the 
binary images of the en-face OCTA image in the retinal superficial layer and the structural OCT image in the 
RPE using the global threshold as described recently (Fig. 1G,H)50. We then removed the projection artifacts from 
the retinal superficial vessels and the shadow artifacts from the preretinal or intraretinal hyperreflective lesions, 
Figure 6. The areas of flow void in the choroid capillary OCTA slab in individual DR severity grades. The non-
flow areas within the CSF in the 29-μm-thick choroid capillary slab of the default setting (A) or the 10-μm-thick 
choriocapillaris layer (B) increase gradually according to individual DR severity grades in all 108 eyes. Areas of 
flow void in the 10-μm-thick choriocapillaris layer in eyes without (C) and with (D) center-involved DME.
www.nature.com/scientificreports/
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e.g., microaneurysms, hemorrhages and hard exudates (Fig. 1K), before we measured the areas of flow void and 
calculated the percentage of the non-flow areas in the total areas without artifacts.
We further investigated the relationship between photoreceptor damage and the non-flow areas in the cho-
riocapillaris layer in eyes with ischemic maculopathy. We first determined ischemic maculopathy of grade 3 
or 4 according to the modified methods described by the ETDRS Report Number 1155. We merged the en-face 
OCTA images in the retinal superficial and deep capillary layers (Fig. 5D) using the colour merge function in 
the analysis plugin WCIF-ImageJ (http://www.uhnresearch.ca/facilities/wcif/imagej/). Ischemic maculopathy 
was defined on the merged OCTA images instead of FA images based on the agreement of two independent 
masked graders. We selected and further evaluated 12 eyes with the outline of the FAZ destroyed for one-half 
or more of the original circumference55. A recent publication demonstrated the association between photore-
ceptor disruption and deep retinal capillary nonperfusion in diabetic eyes45, prompting us to investigate the 
relationship between the EZ status and the flow void in the choriocapillaris layer within the nonperfused areas 
in the deep retinal capillary layer. We prepared the binary images of the non-flow areas in the choriocapillaris 
layer and artifacts (Fig. 5E,F). The regions without intact EZ lines were determined on the B-scan images along 
10 transverse lines (17th, 47th, 77th, 107th, 137th, 167th, 197th, 227th, 257th, and 287th lines from the most 
superior line; Fig. 5G,I,K,L)14. The transverse length of the areas of flow void and those without artifacts were 
measured within the corresponding regions (Fig. 5K,L). We then summed the transverse lengths along all 10 
lines and calculated the percentages of the areas of flow void. Similarly, we evaluated the non-flow areas in the 
regions with intact EZ lines (Fig. 5M,N).
Statistical analysis. The data are expressed as the mean ± SD. After the Kolmogorov–Smirnov test was 
applied to confirm that the dataset was normally distributed, the significant differences were evaluated using 
Student’s t-test or analysis of variance with Bonferroni correction, and the correlation was assessed using Pearson’s 
correlation coefficient.
Figure 7. Association between logMAR VA and the areas of flow void in the choriocapillaris layer. There is a 
modest correlation between logMAR VA and the non-flow areas within the CSF in all 108 eyes (A) and in the 
69 eyes without center-involved DME (B). (C,D) The areas of flow void in the CSF are not associated with either 
logMAR VA or CSF thickness in the 39 eyes with center-involved DME.
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